Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 1, 2015, Pages 178-181

  van Ingen, Jakko ^a   van der Lee, Henrich A ^a   Rijs, Ton A J ^a   Zoll, Jan ^a   Leenstra, Tjalling ^b   Melchers, Willem J G ^a   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

A. fumigatus; Itraconazole; MICs; Posaconazole; Voriconazole

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ECHINOCANDIN; ITRACONAZOLE; POLYENE ANTIBIOTIC AGENT; POSACONAZOLE; PYRROLE DERIVATIVE; STEROL 14ALPHA DEMETHYLASE; TERBINAFINE; VORICONAZOLE; ANTIFUNGAL AGENT; POLYENE;

ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; BROTH DILUTION; CYSTIC FIBROSIS; DRUG MECHANISM; FRANCE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE MUTATION; GENOTYPE; GERMANY; HEALTH SURVEY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; PHENOTYPE; RETROSPECTIVE STUDY; WILD TYPE; ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MISSENSE MUTATION;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AZOLES; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; NETHERLANDS; POLYENES; STEROL 14-DEMETHYLASE;

EID: 84921065207     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku364     Document Type: Article

References (10)

1. Vermeulen E, Lagrou K, Verweij PE. Azole resistance in Aspergillus fumigatus: a growing public health concern. Curr Opin Infect Dis 2013; 26: 493-500.
2. Fischer J, van Koningsbruggen-Rietschel S, Rietschel E et al. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients. J Antimicrob Chemother 2014; 69: 1533-6.
3. 46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill 2012; 17: pii=20326.
4. EUCAST-Subcommittee on Antifungal Susceptibility Testing (EUCASTAFST). http://www.eucast.org.
5. Snelders E, van der Lee HA, Kuijpers J et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5: e219.
6. van der Linden JW, Camps SM, Kampinga GA et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 2013; 57: 513-20.
7. Camps SM, van der Linden JW, Li Y et al. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother 2012; 56: 10-6.
8. Morio F, Aubin GG, Danner-Boucher I et al. High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis. J Antimicrob Chemother 2012; 67: 1870-3.
9. Bader O, Weig M, Reichard U et al. cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob Agents Chemother 2013; 57: 3513-7.
10. Denning DW, Park S, Lass-Florl C et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52: 1123-9.